Quality Standards for Diabetes Care Toolkit

Setting goals/targets

Structure

Evidence of local arrangements to ensure that people with diabetes are able to agree with their health care professional on a documented personalised HbA1c target, and receive an ongoing review of treatment to minimise hypoglycaemia.

Process

(a) The proportion of people with diabetes with a measured HbA1c within the past year.

Numerator	The number of people in the denominator with a measured HbA1c within the past year
Denominator	The number of people with diabetes

(b) The proportion of people with diabetes who have an agreed target for HbA1c within the past year.

Numerator	The number of people in the denominator with an agreed target for HbA1c including a recently documented HbA1c within the past year
Denominator	The number of people with diabetes

(c) The proportion of people with diabetes who have received a review of treatment to minimise hypoglycaemia in the previous 12 months.

Numerator	The number of people in the denominator receiving a review of treatment to minimise hypoglycaemia in the previous 12 months
Denominator	The number of people with diabetes

(d) (Optional) The proportion of people with diabetes achieving their HbA1c target within the past year.

Numerator	The number of people in the denominator achieving their HbA1c target within the past year
Denominator	The number of people with diabetes

The proportion of people with diabetes with a documented HbA1c meeting agreed target within the past year.

Numerator	The number of people in the denominator with a documented HbA1c meeting agreed target
Denominator	The number of people with diabetes

Additional process measures:

The percentage of patients with diabetes with a record of the presence or absence of peripheral pulses in the previous 15 months (see Standard 11).

The percentage of patients with diabetes with a record of neuropathy testing in the previous 15 months (see Standard 11).

The percentage of patients with diabetes who have a record of micro-albuminuria testing in the previous 15 months (see Standard 10).

The percentage of patients with diabetes who have a record of retinal screening in the previous 15 months (see Standard 9).

The percentage of patients with diabetes who have a record of estimated glomerular filtration rate in the previous 15 months (see Standard 9).